These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1528969)
1. [Comparative study of the effectiveness of continuous or intermittent courses of a phlebotonic drug on venous disorders disclosed or aggravated by oral, estrogen-progesterone contraceptives]. Allaert FA; Vin F; Levardon M Phlebologie; 1992; 45(2):167-73. PubMed ID: 1528969 [TBL] [Abstract][Full Text] [Related]
2. [The efficacy of Veinobiase in venous disorders presented in women taking estroprogesterone agents (a statistical study of 2,295 patients)]. Levardon M; Vin F; Allaert FA Rev Fr Gynecol Obstet; 1990 Oct; 85(10):569-74. PubMed ID: 2263839 [TBL] [Abstract][Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
4. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry. Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163 [TBL] [Abstract][Full Text] [Related]
5. [Trial of a phlebotonic agent, a protector of the microcirculation, containing large quantities of active principles, in the treatment of hemorrhage in obstetrics]. Vankemmel P; Le Tallec P Lille Med; 1981; 26(1-2):60-2. PubMed ID: 7206996 [No Abstract] [Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy. Cesarone MR; Belcaro G; Grossi MG; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cacchio M Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):55-61. PubMed ID: 19597413 [TBL] [Abstract][Full Text] [Related]
8. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
10. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323 [TBL] [Abstract][Full Text] [Related]
11. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
12. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"]. Carpentier PH; Mathieu M J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression. Elkind-Hirsch KE; Anania C; Malinak R J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function. Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872 [TBL] [Abstract][Full Text] [Related]